Infantile Spasms Therapeutics Market Poised to Grow at a CAGR of 2.8% by 2024

Infantile Spasms Therapeutics Market Poised to Grow at a CAGR of 2.8% by 2024


Infinium Global Research has added a new report on Infantile Spasms Therapeutics Market. The report presents analysis of global as well as regional markets of infantile spasms therapeutics market over the period of 2016 to 2024.

Infantile spasms (IS) is a rare seizure disorder that occurs in young children, usually under one year of age. Infantile spasm refers to sudden stiffening of the body, the arms, and the legs or forward bending of the head. Infantile spasms are caused by an identifiable underlying condition, such as: Central nervous system infections (such as herpes simplex virus, meningitis, and encephalitis), abnormal brain development or injury, Genetic abnormalities and Neurological disorders with skin lesions.

 

The global market size of infantile spasms market was worth USD XX million and it is projected to reach to USD XX million by 2024. Growing number of births, rising prevalence of infantile spasms and product innovations are factors that is likely to drive the global infantile spasms therapeutics market. According to the National Organization for Rare Disorders, the incidence of infantile spasms is 2 to 3 per 10,000 live births, with a lifetime prevalence of 1.5 to 2 per 10,000 children. However, stringent regulations for product approvals may hinder the growth of the infantile spasms therapeutics market.

Extensive research and development activities, pipeline drugs, and government initiatives are a few more factors projected to fuel the global infantile spasms therapeutics market in the near future.

 

Geographically, North America is expected to dominate the infantile spasms market during the forecast period. U.S held the major market share in the North America region owing to innovation of new products, early adoption of treatment procedures and extensive R&D activities. According to a study carried out in U.S around 2K to 4K new cases of infantile spasms disorder occur in the U.S. every year. The Asia pacific region is expected to expand at the highest CAGR during the forecast period owing to rising awareness about this disease and its treatment procedures.

 

Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global infantile spasms therapeutics market but also make strategic decisions to capture the most lucrative markets in the near future.

The market size is presented in terms of value for the historic year 2016 and estimated for forecast period of 2018-2024.

 

Get 15% discount for early purchase of global infantile spasms therapeutics market report by clicking the following link, Use code IGRD15 to request the discount in the given form

https://www.infiniumglobalresearch.com/reports/request-discount/1310

 

The recent report identified that North America dominated the global infantile spasms therapeutics market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the infantile spasms therapeutics market worldwide.

The report segments the global infantile spasms therapeutics market on the basis of Dosage and Route of Administration.

 

Global Infantile Spasms Therapeutics Market by Dosage

·         Solid

·         Liquid

 

Global Infantile Spasms Therapeutics Market by Route of Administration

·         Oral

·         Parental

 

Companies Profiled in the Report

·         Valerion Therapeutics

·         Anavex Life Sciences Corp

·         GW Pharmaceuticals

·         MALLINCKRODT

·         H. LUNDBECK A/S

·         ORPHELIA Pharma SA

·         INSYS Therapeutics Inc.

·         ETROPHIN INC.

·         CATALYSTPHARMA

 

About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.


© 2024. Infinium Global Research LLP. All Rights Reserved.